Cargando…

MicroRNA-331 inhibits development of gastric cancer through targeting musashi1

BACKGROUND: The molecular mechanisms involved in microRNAs (miRNAs) have been extensively investigated in gastric cancer (GC). However, how miR-331 regulates GC pathogenesis remains unknown. AIM: To illuminate the effect of miR-331 on cell metastasis and tumor growth in GC. METHODS: The qRT-PCR, CCK...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Lei-Ying, Song, Guang-Le, Zhai, Xiao-Qian, Wang, Li, Liu, Qin-Lai, Zhou, Ming-Shun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755110/
https://www.ncbi.nlm.nih.gov/pubmed/31558975
http://dx.doi.org/10.4251/wjgo.v11.i9.705
Descripción
Sumario:BACKGROUND: The molecular mechanisms involved in microRNAs (miRNAs) have been extensively investigated in gastric cancer (GC). However, how miR-331 regulates GC pathogenesis remains unknown. AIM: To illuminate the effect of miR-331 on cell metastasis and tumor growth in GC. METHODS: The qRT-PCR, CCK8, Transwell, cell adhesion, Western blot, luciferase reporter and xenograft tumor formation assays were applied to explore the regulatory mechanism of miR-331 in GC. RESULTS: Downregulation of miR-331 associated with poor prognosis was detected in GC. Functionally, miR-331 suppressed cell proliferation, metastasis and tumor growth in GC. Further, miR-331 was verified to directly target musashi1 (MSI1). In addition, miR-331 inversely regulated MSI1 expression in GC tissues. Furthermore, upregulation of MSI1 weakened the inhibitory effect of miR-331 in GC. CONCLUSION: miR-331 inhibited development of GC through targeting MSI1, which may be used as an indicator for the prediction and prognosis of GC.